e-learning
resources
Virtual 2020
Pre-Congress Content
COPD phenotypes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD?
S. Liška (Zagreb, Croatia), A. Vidakovic (Zagreb, Croatia), I. Rako (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia)
Source:
Virtual Congress 2020 – COPD phenotypes
Session:
COPD phenotypes
Session type:
E-poster session
Number:
2447
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Liška (Zagreb, Croatia), A. Vidakovic (Zagreb, Croatia), I. Rako (Zagreb, Croatia), A. Vukic Dugac (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia). Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD?. 2447
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Nutritional and systemic inflammatory parameters in patients with COPD exacerbation: relation with functional parameters
Source: Eur Respir J 2005; 26: Suppl. 49, 297s
Year: 2005
Associations of COPD severity and severity of exacerbation with sputum microbiologic profile and long-term survival
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Clinical parameters predict the risk of acute exacerbation of COPD better than bronchial obstruction degree
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001
Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD?
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Does a predominant clinical COPD phenotype predict different outcome responses to pulmonary rehabilitation?
Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care
Year: 2012
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Factors associated with poor prognostic outcome in acute exacerbation of COPD
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009
Non-invasive inflammatory markers can predict diagnosis, severity and stability of paediatric asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 122s
Year: 2006
Relationship of systemic inflammation and autoimmunity to clinically relevant outcomes in COPD
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
Predicting treatment outcomes following an exacerbation of airways disease
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Do worse scores on patient-reported outcomes predict the progression of interstitial lung disease (ILD)?
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
Clinical parameters for predicting 3-month FEV
1
response of obstructive lung diseases in elderly patients
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009
Effect of comorbidities on severity and clinical parameters of COPD
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Clinical features and functional parameters predict the probability of ACO in patients with asthma and COPD
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Can asthma severity be a predictor of exacerbation severity?
Source: Eur Respir J 2003; 22: Suppl. 45, 371s
Year: 2003
Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Measuring inflammation inpaediatric severe asthma: biomarkers in clinical practice
Source: Breathe, 16 (1) 190301; 10.1183/20734735.0301-2019
Year: 2020
Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010
The relationship of comorbidities with clinical and phsyiological parameters in COPD
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept